22 October – Webinar in connection with interim report
On 22 October 2026, Alligator hosted a webinar for investors, analysts and media, where CEO Søren Bregenholt and CFO Johan Giléus presented and commented on the 2026 July-September interim report, which was followed by a Q&A session.
The call was held in English. A recording can be found following this link.
LATEST NEWS
Alligator Bioscience AB reports financial results for the period 1 January – 30 September 2026 and provides a business update
Rights issue completed: The rights issue was subscribed to approximately 17.1 percent, and guarantee commitments covered a further 29.7 perc …
Invitation to Alligator Bioscience’s interim report call on 22 October 2026
Lund, Sweden – Alligator Bioscience (Nasdaq Stockholm: ATORX), a biotechnology company whose principal asset is a financial interest i …
Alligator Bioscience appoints Johan Giléus as CEO – Søren Bregenholt to step down at year-end
Johan Giléus, currently CFO, has been appointed CEO effective 1 January 2027 Søren Bregenholt will remain CEO until 31 Decembe …